Skip to main content
. 2021 Jan-Feb;66(1):67–73. doi: 10.4103/ijd.IJD_206_20

Table 3.

Changes in TNF between treatment arms

TNF PPD group (n=9) Mw group (n=11) MMR group (n=12) P (between groups)
Baseline 247.22±359.50 250.45±582.40 103.50±64.01 0.165
83 (60, 287.5) 58 (52.25, 84.25) 73.5 (65.5, 133.5)
End of treatment 129.22±179.19 51.82±4.94 55.75±10.70 0.281
60 (51, 101.75) 52 (49.5, 55) 54.5 (51, 65)
P (within groups) 0.203 0.042 0.0005

P-value for between groups by Kruskal–Wallis ANOVA. P-value for within groups by Wilcoxon test